التفاصيل البيبلوغرافية
| العنوان: |
Bayer Sees Another Year of Falling Profit, Keeps Structure. |
| المؤلفون: |
Loh, Tim |
| المصدر: |
Bloomberg.com. 3/5/2024, p1-1. 1p. |
| مصطلحات موضوعية: |
*DRUG patents, *AGRICULTURAL prices, *INVESTORS, *CHIEF executive officers |
| الشركة/الكيان: |
BAYER AG |
| مستخلص: |
Bayer AG has projected another year of declining profit and has committed to improving its existing divisions rather than breaking them up. The company expects core earnings to drop to as low as €5.10 per share in 2024, lower than analysts' expectations. CEO Bill Anderson has outlined his strategy for addressing the company's challenges, including debt, legal issues, bureaucracy, and drug patent expirations. Anderson has also defended the safety and importance of the weed-killer Roundup, which has faced lawsuits claiming it causes cancer. Bayer's sales and profit fell last year, and the company anticipates further declines due to low agriculture product prices and increased competition. [Extracted from the article] |
|
Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Business Source Index |
